Zytux Rituximab Injection 500mg 50ml In Pakistan

Zytux Rituximab Injection 500mg 50ml In Pakistan

Zytux Rituximab Injection 500mg/50mL is a prescription biologic medicine containing rituximab, a monoclonal antibody that targets the CD20 protein on certain B cells. It is used by specialists to treat specific blood cancers and autoimmune conditions, depending on the patient's diagnosis and the approved indication.

The 500mg/50mL presentation contains rituximab at a concentration of 10mg/mL. It is administered by intravenous infusion in a suitable medical facility under qualified healthcare supervision.

Key Benefits

• Targeted Treatment: Targets CD20-positive B cells involved in certain diseases.

• Blood Cancer Therapy: May be used to treat certain types of non-Hodgkin lymphoma and other eligible blood cancers.

• Autoimmune Disease Management: May be prescribed for selected autoimmune conditions when clinically appropriate.

• Specialist Treatment Option: Can be incorporated into an individualized treatment plan, alone or with other medicines, depending on the condition.

• Monitored Administration: Infusion in a medical facility allows healthcare professionals to monitor treatment response and potential reactions.

Treatment suitability and outcomes vary by diagnosis and individual medical circumstances.

Specifications

• Product Name: Zytux Rituximab Injection

• Active Ingredient: Rituximab

• Strength: 500mg/50mL

• Concentration: 10mg/mL

• Dosage Form: Concentrate for solution for infusion

• Medicine Type: Monoclonal antibody / biologic medicine

• Route of Administration: Intravenous infusion

• Pack Size: 50mL vial

• Storage: Generally refrigerated at 2–8°C; do not freeze. Follow the product-specific package insert.

• Prescription Status: Prescription medicine

How to Use

1. Medical Consultation: Use only when prescribed by an appropriate specialist.

2. Professional Preparation: The medicine must be diluted and prepared by trained healthcare professionals according to the manufacturer's instructions.

3. Intravenous Infusion: It is administered slowly through a vein in a properly equipped medical facility. It must not be given as a rapid injection or self-administered.

4. Individualized Dosage: The dose and treatment schedule depend on the condition being treated, the prescribed treatment protocol, and the patient's clinical circumstances.

5. Monitoring: Medical staff monitor for infusion reactions and other adverse effects during treatment.

6. Proper Storage: Maintain the required cold chain and do not use the product if expired or improperly stored.